Trisha Suppes
#126,434
Most Influential Person Now
Professor at Stanford University in the School of Medicine, Department of Psychiatry and Behavioral Sciences
Trisha Suppes's AcademicInfluence.com Rankings
Trisha Suppesphilosophy Degrees
Philosophy
#8249
World Rank
#11591
Historical Rank
Logic
#5284
World Rank
#6671
Historical Rank
Download Badge
Philosophy
Why Is Trisha Suppes Influential?
(Suggest an Edit or Addition)According to Wikipedia, Trisha Suppes is a professor at Stanford University in the School of Medicine, Department of Psychiatry and Behavioral Sciences. She also works at the VA Palo Alto Health Care System as director of the Bipolar and Depression Research Program. She is noted for being an expert in the treatment and management of bipolar disorder. She been the author or co-author of over 200 peer-reviewed articles and has written numerous academic textbooks for the treatment of Bipolar Disorder. Suppes' recent work includes exploring the biological basis of mood disorders.
Trisha Suppes's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder (2018) (891)
- The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation (2004) (847)
- The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. (2005) (815)
- Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. (2001) (703)
- The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. (2001) (511)
- Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. (2000) (496)
- A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder (2000) (446)
- Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. (2002) (418)
- Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. (2003) (413)
- The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. (2009) (388)
- Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. (1991) (371)
- Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. (2003) (352)
- Management of bipolar disorder during pregnancy and the postpartum period. (2004) (350)
- Correlates of overweight and obesity in 644 patients with bipolar disorder. (2002) (337)
- The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. (2005) (335)
- Bipolar disorders (2018) (334)
- Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. (2007) (317)
- Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. (2010) (305)
- Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline (2006) (299)
- Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. (2000) (297)
- Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. (2004) (291)
- Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone (2004) (288)
- Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. (2006) (287)
- Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. (2004) (266)
- Early physical and sexual abuse associated with an adverse course of bipolar illness (2002) (266)
- Olanzapine versus divalproex in the treatment of acute mania. (2002) (258)
- Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. (1999) (254)
- Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. (2003) (244)
- Double-Blind, Randomized, Placebo-Controlled Trials of Ethyl-Eicosapentanoate in the Treatment of Bipolar Depression and Rapid Cycling Bipolar Disorder (2006) (223)
- A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. (2007) (222)
- High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure (2002) (221)
- Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127). (2009) (216)
- Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. (1993) (216)
- Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). (2008) (216)
- Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study (2001) (211)
- Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. (2003) (210)
- Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study. (2006) (206)
- Open-label adjunctive topiramate in the treatment of bipolar disorders (2000) (205)
- Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. (2003) (193)
- Bipolar II disorder: arguments for and against a distinct diagnostic entity. (2008) (184)
- Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. (2010) (183)
- Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. (2005) (183)
- Early Intervention in Bipolar Disorder. (2018) (177)
- The poor prognosis of childhood-onset bipolar disorder. (2007) (176)
- The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. (2001) (172)
- Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. (2002) (169)
- Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. (2013) (165)
- Validation of the prospective NIMH-Life-Chart Method (NIMH-LCMTM-p) for longitudinal assessment of bipolar illness (2000) (164)
- The McLean–Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis (2000) (162)
- Atypical antipsychotics in bipolar depression: potential mechanisms of action. (2005) (159)
- Pediatric‐Onset Bipolar Disorder: A Neglected Clinical and Public Health Problem Gianni (1995) (156)
- Mood Symptoms during Corticosteroid Therapy: A Review (1998) (153)
- Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. (2005) (152)
- Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. (2011) (147)
- A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. (2003) (146)
- Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum Disorders: Recent Developments and Current Perspectives (2007) (146)
- Cellular and synaptic physiology and epileptogenesis of developing rat neocortical neurons in vitro. (1987) (144)
- Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. (2003) (144)
- Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. (2004) (142)
- Genetics and intermediate phenotypes of the schizophrenia—bipolar disorder boundary (2010) (139)
- High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder (2003) (139)
- An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). (2003) (135)
- A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. (2000) (135)
- Drug abuse and bipolar disorder: comorbidity or misdiagnosis? (2001) (132)
- Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. (2006) (132)
- Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. (2001) (131)
- Bipolar rapid cycling: focus on depression as its hallmark. (2001) (131)
- Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. (2002) (129)
- Challenges in the management of bipolar depression. (2005) (128)
- Mood Changes During Prednisone Bursts in Outpatients With Asthma (2002) (123)
- Clozapine in the treatment of dysphoric mania (1992) (122)
- Valproate Is Associated with New-Onset Oligoamenorrhea with Hyperandrogenism in Women with Bipolar Disorder (2006) (122)
- Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. (2009) (120)
- Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. (2009) (118)
- Dimensions and the psychosis phenotype (2007) (117)
- Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study. (2016) (116)
- Brief Psychiatric Rating Scale Expanded Version: How do new items affect factor structure? (2005) (113)
- Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. (2003) (112)
- Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial. (2019) (111)
- Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project. (1999) (110)
- The Stanley Foundation Bipolar Network (2001) (110)
- Reproductive function and risk for PCOS in women treated for bipolar disorder. (2005) (107)
- Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial (2017) (101)
- Olanzapine in treatment-resistant bipolar disorder. (1998) (97)
- Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. (2010) (95)
- Is postictal electrical silence a predictor of response to electroconvulsive therapy? (1996) (94)
- Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. (2003) (93)
- Guidelines for the recognition and management of mixed depression. (2017) (93)
- Developing novel treatments for mood disorders: accelerating discovery (2002) (92)
- Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. (2008) (86)
- Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers (2007) (85)
- Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. (1996) (84)
- Incidence of childhood-onset bipolar illness in the USA and Europe (2008) (83)
- The Texas medication algorithm project: clinical results for schizophrenia. (2004) (82)
- A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. (2008) (78)
- Lamotrigine in the treatment of bipolar depression (1999) (76)
- Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder (2015) (76)
- Clozapine Treatment of Children and Adolescents with Bipolar Disorder and Schizophrenia: A Clinical Case Series (1995) (75)
- Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder. (2001) (75)
- The longitudinal course of bipolar disorder. (2000) (74)
- Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia (2013) (71)
- Gabapentin in the acute treatment of refractory bipolar disorder. (1999) (68)
- Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: A report of three cases (1994) (67)
- Efficacy of quetiapine monotherapy for the treatment of depressive episodes in bipolar I disorder: a post hoc analysis of combined results from 2 double-blind, randomized, placebo-controlled studies. (2008) (67)
- Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. (2004) (66)
- Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. (2009) (65)
- Discontinuation of Maintenance Treatment in Bipolar Disorder: Risks and Implications (1993) (65)
- A review of randomized, controlled clinical trials in acute mania. (2000) (65)
- Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. (2009) (64)
- Practice guideline for the treatment of patients with bipolar disorder, second edition. (2002) (63)
- Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial. (2005) (63)
- Tiagabine in treatment refractory bipolar disorder: a clinical case series. (2002) (63)
- A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. (2004) (62)
- A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders. (2007) (61)
- Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. (2006) (60)
- Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project (2005) (60)
- Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. (2005) (60)
- Lamotrigine for the treatment of bipolar disorder: a clinical case series. (1999) (60)
- Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder. (2013) (59)
- More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment. (2014) (56)
- The Texas Medication Algorithm Project (2004) (55)
- The Stanley Foundation Bipolar Network (2001) (55)
- Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial. (2007) (54)
- Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany (2011) (54)
- Review of the Use of Topiramate for Treatment of Bipolar Disorders (2002) (54)
- Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. (1998) (54)
- Quetiapine for the treatment of bipolar II depression: Analysis of data from two randomized, double-blind, placebo-controlled studies (2008) (52)
- Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. (1994) (52)
- Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network. (2016) (49)
- Longitudinal Follow-up of Reproductive and Metabolic Features of Valproate-Associated Polycystic Ovarian Syndrome Features: A Preliminary Report (2006) (49)
- Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder. (2017) (49)
- Combined Clozapine and Electroconvulsive Therapy. (1993) (48)
- The relationship between affective state and the rhythmicity of activity in bipolar disorder. (2014) (47)
- Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study (2007) (47)
- Gabapentin for treatment of bipolar and schizoaffective disorders. (1997) (46)
- Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition (2018) (46)
- Psychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia (2001) (46)
- Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism. (2007) (46)
- A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. (2008) (46)
- Stereotypical changes in the pattern and duration of long-term potentiation expressed at postnatal days 11 and 15 in the rat hippocampus. (1993) (46)
- Are bipolar mood symptoms affected by the phase of the menstrual cycle? (2008) (45)
- Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts. (2016) (45)
- More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany (2013) (45)
- Toward a Valid Animal Model of Bipolar Disorder: How the Research Domain Criteria Help Bridge the Clinical-Basic Science Divide (2016) (45)
- More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention (2017) (44)
- Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data. (2005) (43)
- Increased parental history of bipolar disorder in the United States: association with early age of onset (2014) (43)
- The influence of dopamine of epileptiform burst activity in hippocampal pyramidal neurons (1985) (43)
- Human amygdala engagement moderated by early life stress exposure is a biobehavioral target for predicting recovery on antidepressants (2016) (43)
- Recurrence in Bipolar I Disorder: A Post Hoc Analysis Excluding Relapses in Two Double-blind Maintenance Studies (2006) (42)
- Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists. (2007) (42)
- Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison. (2017) (41)
- Depressive relapse during lithium treatment associated with increased serum thyroid‐stimulating hormone: results from two placebo‐controlled bipolar I maintenance studies (2009) (41)
- Measuring use of outpatient care among mentally ill individuals: a comparison of self reports and provider records (1999) (41)
- Treating bipolar illness: focus on treatment algorithms and management of the sleep-wake cycle. (1999) (38)
- Age of onset of bipolar disorder: Combined effect of childhood adversity and familial loading of psychiatric disorders. (2016) (37)
- Correlates of Treatment-Emergent Mania Associated With Antidepressant Treatment in Bipolar Depression (2011) (36)
- Six-Month Prospective Life Charting of Mood Symptoms with Lamotrigine Monotherapy Versus Placebo in Rapid Cycling Bipolar Disorder (2008) (36)
- Comparison of objective and subjective assessments of sleep time in subjects with bipolar disorder. (2013) (36)
- Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder. (2012) (35)
- Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study (2019) (35)
- Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depression (2020) (35)
- Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement (2018) (35)
- A randomized controlled trial of MoodSwings 2.0: An internet‐based self‐management program for bipolar disorder (2018) (34)
- Implementing guidelines and systems of care: Experiences with the Texas Medication Algorithm Project (TMAP) (1999) (34)
- Presentation and prevalence of PTSD in a bipolar disorder population: a STEP-BD examination. (2013) (34)
- Assessment of beliefs in the effectiveness of acupuncture for treatment of psychiatric symptoms. (2002) (34)
- Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. (2013) (33)
- Developing a clinical translational neuroscience taxonomy for anxiety and mood disorder: protocol for the baseline-follow up Research domain criteria Anxiety and Depression (“RAD”) project (2016) (33)
- Low doses of clozapine may stabilize treatment–resistant bipolar patients (2005) (32)
- Awareness of Metabolic Concerns in Patients With Bipolar Disorder: A Survey of European Psychiatrists (2008) (32)
- Omega-3 fatty acids in bipolar disorder: clinical and research considerations. (2006) (31)
- Treatment of Rapid-Cycling Bipolar Disorder (2004) (31)
- Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Bipolar Disorder: A Novel, Practical, Patient-Centered Guide for Clinicians. (2016) (31)
- A clinically significant interaction between clozapine and valproate. (1995) (30)
- MAINTENANCE TREATMENT WITH QUETIAPINE WHEN COMBINED WITH EITHER LITHIUM OR DIVALPROEX IN BIPOLAR I DISORDER: ANALYSIS OF TWO LARGE RANDOMIZED, PLACEBO‐CONTROLLED TRIALS (2013) (30)
- The ENGAGE study: Integrating neuroimaging, virtual reality and smartphone sensing to understand self-regulation for managing depression and obesity in a precision medicine model. (2017) (30)
- B : ALGORITHMS FOR THE TREATMENT OF BIPOLAR, MANIC-DEPRESSIVE ILLNESS (1995) (30)
- The Bipolar Book History, Neurobiology, and Treatment (2015) (29)
- Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression (2020) (29)
- First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo. (2013) (29)
- Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study. (2017) (28)
- Catching up on health outcomes: the Texas Medication Algorithm Project. (2003) (28)
- Multigenerational Positive Family History of Psychiatric Disorders Is Associated With a Poor Prognosis in Bipolar Disorder. (2015) (28)
- LITHIUM WITHDRAWAL IN BIPOLAR DISORDER: IMPLICATIONS FOR CLINICAL PRACTICE AND EXPERIMENTAL THERAPEUTICS RESEARCH (1996) (27)
- Evidence-based long-term treatment of bipolar II disorder. (2002) (27)
- Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. (2012) (26)
- Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder (2004) (25)
- Gastrointestinal side-effects after switch to generic valproic acid. (1998) (25)
- Treatment of corticosteroid-induced mood changes with olanzapine. (1999) (25)
- Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. (2004) (25)
- The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder (2020) (25)
- Predominant polarity in bipolar disorders: refining or redefining diagnosis? (2015) (24)
- Mental health care from the public perspective: the Texas Medication Algorithm Project. (1999) (24)
- Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies (2013) (24)
- Major depressive disorder with subthreshold hypomania (mixed features): Clinical characteristics of patients entered in a multiregional, placebo-controlled study (2016) (23)
- Use of quetiapine in bipolar disorder: a case series with prospective evaluation. (2004) (23)
- Effects of clozapine on sleep in bipolar and schizoaffective disorders (2004) (22)
- Reproductive Health and Bipolar Disorder (2006) (22)
- A psychometric evaluation of the clinician‐rated Quick Inventory of Depressive Symptomatology (QIDS‐C16) in patients with bipolar disorder (2009) (22)
- Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. (2022) (22)
- More illness in offspring of bipolar patients from the U.S. compared to Europe. (2016) (22)
- Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state (2018) (21)
- Treatment of bipolar mania with atypical antipsychotics (2004) (21)
- Corrigendum to “Effectiveness of the Extended Release Formulation of Quetiapine as Monotherapy for the Treatment of Acute Bipolar Depression” [J. Affect. Disord. 121 (1–2) (2010) 106–115] (2014) (21)
- Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. (2016) (20)
- Obesity and obstetric complications are associated with rapid-cycling in Italian patients with bipolar disorder. (2017) (20)
- Testing a clinical staging model for bipolar disorder using longitudinal life chart data (2018) (20)
- The relationship between self-reported borderline personality features and prospective illness course in bipolar disorder (2017) (20)
- Methodological issues in developing new acute treatments for patients with bipolar illness (2000) (20)
- More Medical Comorbidities in Patients With Bipolar Disorder From the United States Than From the Netherlands and Germany (2014) (20)
- The safety, acceptability, and effectiveness of acupuncture as an adjunctive treatment for acute symptoms in bipolar disorder. (2009) (20)
- Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis. (2017) (19)
- A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough? (2020) (19)
- Implementation of the Texas Medication Algorithm Project patient and family education program. (2006) (19)
- Treatment of bipolar depression (1998) (18)
- A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder. (2014) (18)
- Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials (2017) (18)
- Algorithms for the treatment of bipolar manic-depressive illness. (1995) (18)
- Increases in multiple psychiatric disorders in parents and grandparents of patients with bipolar disorder from the USA compared with The Netherlands and Germany (2015) (18)
- An empirical analysis of cost outcomes of the Texas Medication Algorithm Project. (2006) (18)
- Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies (2019) (18)
- The Quick Inventory of Depressive Symptomatology (Clinician and Self-Report Versions) in Patients With Bipolar Disorder (2010) (17)
- Cholinergic enhancement of penicillin-induced epileptiform discharges in pyramidal neurons of the guinea pig hippocampus (1983) (17)
- Age at Onset of Bipolar Disorder Related to Parental and Grandparental Illness Burden. (2016) (17)
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations (2021) (17)
- Multivariate analysis of bipolar mania: retrospectively assessed structure of bipolar I manic and mixed episodes in randomized clinical trial participants. (2013) (17)
- Treatment algorithm use to optimize management of symptomatic patients with a history of mania. (1998) (17)
- Mixed features in major depressive disorder: diagnoses and treatments (2017) (17)
- Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo. (2009) (17)
- Advances in bipolar disorder: selected sessions from the 2011 International Conference on Bipolar Disorder (2011) (16)
- Further Evidence of a Cohort Effect in Bipolar Disorder: More Early Onsets and Family History of Psychiatric Illness in More Recent Epochs. (2016) (16)
- Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin. (2020) (16)
- Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar Network (2019) (16)
- Online ethics: where will the interface of mental health and the internet lead us? (2017) (16)
- Sensitivity of neuronal dopamine response in the substantia nigra and ventral tegmentum to clozapine, metoclopramide and SCH 23390 (1987) (15)
- Medication Algorithms for Bipolar Disorder (1999) (15)
- Multigenerational transmission of liability to psychiatric illness in offspring of parents with bipolar disorder (2018) (15)
- New findings from the bipolar collaborative network: Clinical implications for therapeutics (2006) (15)
- Validity, Reliability, and Responsiveness of a New Measure of Health-Related Quality of Life in Children with Immune Thrombocytopenic Purpura: The Kids' ITP Tools (2007) (15)
- The atypical antipsychotic sertindole: a case series. (1997) (15)
- Clozapine associated with decreased suicidality in bipolar disorder: a case report. (1999) (14)
- Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network (2007) (14)
- A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression. (2019) (14)
- Patterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of mania (2015) (14)
- Comparison of Two Anticonvulsants in a Randomized, Single-Blind Treatment of Hypomanic Symptoms in Patients with Bipolar Disorder (2007) (13)
- A clinical model for identifying an inflammatory phenotype in mood disorders. (2019) (13)
- A double‐blind, placebo‐controlled trial of eicosapentanoic acid in rapid cycling bipolar disorder (2002) (13)
- Presentations of depression in bipolar illness (2002) (13)
- Efficacy of divalproex therapy for schizoaffective disorder. (2000) (12)
- Comparison of the internal state scale to clinician-administered scales in asthma patients receiving corticosteroid therapy. (2000) (12)
- Quality of Care Measures for the Treatment of Bipolar Disorder (2005) (12)
- Double jeopardy in the United States: Early onset bipolar disorder and treatment delay (2020) (11)
- A cautionary note when using zonisamide in youths: a case report of association with toxic epidermal necrolysis. (2004) (11)
- P0155 - Maintenance treatment in bipolar I disorder with Quetiapine in combination with Lithium/Divalproex: A placebo-controlled, randomized trial (North American trial D1447C00127) (2008) (11)
- Peripheral inflammatory biomarkers define biotypes of bipolar depression (2021) (11)
- Adding Increased Energy or Activity to Criterion (A) of the DSM-5 Definition of Hypomania and Mania: Effect on the Diagnoses of 907 Patients From the Bipolar Collaborative Network. (2019) (11)
- Olanzapine combined with mood stabilizers in prevention of recurrence in bipolar disorder: An 18-month study (2002) (11)
- The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management (2022) (10)
- Prevalence of impaired kidney function in patients with long‐term lithium treatment: A systematic review and meta‐analysis (2021) (10)
- The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based study (2018) (10)
- Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression (2020) (10)
- Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder. (2004) (10)
- A new algorithm for treating schizophrenia. (1998) (10)
- Increased Suicidal Ideation in Patients with Co-Occurring Bipolar Disorder and Post-Traumatic Stress Disorder (2017) (10)
- Understanding mechanisms of integrated behavioral therapy for co-occurring obesity and depression in primary care: a mediation analysis in the RAINBOW trial. (2020) (10)
- Is there a role for antidepressants in the treatment of bipolar II depression? (2010) (10)
- Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study (2015) (10)
- Progressing MoodSwings. The upgrade and evaluation of MoodSwings 2.0: An online intervention for bipolar disorder. (2017) (9)
- Medication optimization during clozapine treatment. (1996) (9)
- Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder. (2015) (9)
- Neuroimaging procedures and related acquisitions in bipolar disorder: state of the art. (2014) (9)
- Axis II Personality Disorders Are Linked to an Adverse Course of Bipolar Disorder (2018) (9)
- 107. A one year randomized trial of clozapine vs. usual care in bipolar I patients (1996) (9)
- Special treatment issues: maintaining and discontinuing psychotropic medications. (1997) (8)
- The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting (2003) (8)
- Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project (2003) (7)
- Effectiveness of the New Extended-release Formulation of Quetiapine as Monotherapy for the Treatment of Acute Bipolar Depression (Trial D144CC00002) (2009) (7)
- Effects of infliximab on brain neurochemistry of adults with bipolar depression. (2020) (7)
- The role of childhood adversity in the development of medical comorbidities associated with bipolar disorder (2012) (7)
- Early changes in neural circuit function engaged by negative emotion and modified by behavioural intervention are associated with depression and problem-solving outcomes: A report from the ENGAGE randomized controlled trial (2021) (7)
- An empirical analysis of cost outcomes of the Texas Medication Algorithm Project (2006) (6)
- A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression (2021) (6)
- Problem-solving therapy-induced amygdala engagement mediates lifestyle behavior change in obesity with comorbid depression: a randomized proof-of-mechanism trial. (2021) (6)
- Bipolar rapid cycling (2001) (6)
- Lamotrigine in rapid cycling bipolar disorder: Predictors of response in a double-blind, placebo-controlled maintenance study (2001) (6)
- The Prevalence and Diagnostic Validity of Short-Duration Hypomanic Episodes and Major Depressive Episodes (2016) (6)
- Olanzapine versus divalproex sodium for bipolar mania: a 47-week study (2002) (6)
- 25 Years of the International Bipolar Collaborative Network (BCN) (2021) (6)
- Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders; a summary of two previous studies (2000) (6)
- A late slow depolarization unmasked in the presence of tetraethylammonium in neonatal rat sympathetic neurons in vitro (1984) (5)
- Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight (2018) (5)
- Management of Bipolar Disorder During Pregnancy The Postpartum Period (2005) (5)
- Self-reported participation in nonpharmacologic treatments for bipolar disorder. (2004) (5)
- Increasing access to clinical research using an innovative mobile recruitment approach: The (MoRe) concept (2020) (5)
- Olanzapine cotherapy in prevention of recurrence in bipolar disorder (2002) (5)
- Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. (2014) (5)
- Relationship of comorbid personality disorders to prospective outcome in bipolar disorder. (2020) (5)
- Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States. (2014) (5)
- Depression With Mixed Features in Major Depressive Disorder: A New Diagnosis or There All Along? (2018) (4)
- An investigation of water lithium concentrations and rates of violent acts in 11 Texas counties: can an association be easily shown? (2008) (4)
- More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: implications for psychiatric illness in the offspring (2018) (4)
- Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder (2013) (4)
- Switching outpatients between atypical antipsychotics (2000) (4)
- Co-occurrence of serious or undiagnosed medical conditions with bipolar disorder preventing clinical trial randomization: a case series. (2012) (3)
- Impact of modification to DSM-5 criterion A for hypomania/mania in newly diagnosed bipolar patients: findings from the prospective BIO study (2021) (3)
- Attitudes on pharmacogenetic testing in psychiatric patients with treatment‐resistant depression (2020) (3)
- Efficacy Of Lurasidone In Major Depression With Mixed Features: Pattern Of Improvement In Depressive And Manic Symptoms (2016) (3)
- Mediating Effects of Neural Targets on Depression, Weight and Anxiety Outcomes of an Integrated Collaborative Care Intervention: The ENGAGE-2 Mechanistic Pilot RCT (2021) (3)
- Mediating Effects of Neural Targets on Depression, Weight, and Anxiety Outcomes of an Integrated Collaborative Care Intervention: The ENGAGE-2 Mechanistic Pilot Randomized Clinical Trial (2022) (3)
- Novel and emerging treatments for major depression (2022) (3)
- An online intervention for bipolar disorder Moodswings 2.0: www.moodswings.net.au (2013) (2)
- Clozapine treatment of children and adolescents (1994) (2)
- Switch rate on venlafaxine compared with bupropion and sertraline (2004) (2)
- Dr. Altshuler and Colleagues Reply (2004) (2)
- Forum. What are the mental health complications of steroid therapy? (2000) (2)
- 105. Clozapine treatment of children and adolescents: A four year follow-up (1996) (2)
- and Carbamazepine in Children and Adolescents With Bipolar Disorder (2000) (2)
- Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: A consensus definition – CORRIGENDUM (2019) (2)
- Moving the Field Forward 09 : 0010 : 30 THE INTERNATIONAL SOCIETY OF BIPOLAR DISORDERS TASK FORCE ON THE NOMENCLATURE OF COURSE AND OUTCOME IN BIPOLAR DISORDERS (2007) (2)
- What's Up with Bipolar Disorder? (2011) (2)
- Capgras'and Fregoli's syndromes in one family. (1996) (2)
- Olanzapine versus divalproex sodium for bipolar mania in rapid cyclers (2002) (2)
- The factor structure of depressive symptoms in patients with obesity enrolled in the RAINBOW clinical trial. (2020) (2)
- Letter to the Editor in response to 2012 article by Frances and Jones (2014) (2)
- PW01-37 - Long-term Efficacy of Quetiapine In Combination With Lithium or Divalproex on Mixed Symptoms In Bipolar I Disorder (2010) (1)
- How rare is bipolar disorder not otherwise specified? (2003) (1)
- Mania and bipolar depression: complementing not opposing poles—a post-hoc analysis of mixed features in manic and hypomanic episodes (2021) (1)
- Illnesses in siblings of US patients with bipolar disorder relate to multigenerational family history and patients severity of illness. (2017) (1)
- Subsyndromal depression and impaired life functioning in bipolar disorder (2005) (1)
- Problem Solving Therapy-induced Amygdala Engagement Mediates Weight Loss and Lifestyle Behavior Change in Patients With Obesity and Depression: A Randomized Controlled Trial (2020) (1)
- Drs. Suppes and Vieta Reply (2009) (1)
- Investigation of a Capnometry Guided Respiratory Intervention in the Treatment of Posttraumatic Stress Disorder (2021) (1)
- Mood stabilizer and subsequent need for adjunctive antidepressant: naturalistic follow up of the SFBN (2007) (1)
- Treating rapid cycling bipolar disorder with novel medications (2006) (1)
- Mechanistic self-regulation targets in integrated behavior therapy for obese and depressed adults: Rainbow-engage study (2017) (1)
- Prevalence rate of mixed depression and its impact on remission: a controlled evaluation (2009) (1)
- Mixed depression in bipolar disorder : prevalence rate and clinical correlates during naturalistic follow up (2010) (1)
- Impact of Modification to DSM-5 Criterion A for Hypomania/Mania in Newly Diagnosed/First Episode Bipolar Patients – Findings From the Prospective BIO Study (2020) (1)
- P.2.b.013 Lurasidone for the treatment of major depressive disorder with mixed features: a randomised, double-blind, placebo-controlled 6 week trial (2015) (1)
- Altered Anterior Insula Function Precedes Improved Problem Solving in a Mechanistic Treatment Trial for Depression (2020) (1)
- LURASIDONE FOR MAJOR DEPRESSIVE DISORDER WITH MIXED FEATURES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 6 WEEK TRIAL (2015) (1)
- The relationship between circadian gene single nucleotide polymorphisms and clinical and behavioral assessments of sleep and rhythms and course of illness characteristics in subjects with bipolar type I disorder (2019) (1)
- The safety, acceptability, and effectiveness of acupuncture as an adjunctive treatment for acute symptoms in bipolar disorder (2011) (1)
- Mental health care from the public perspective : The Texas Medication Algorithm Project. Discussion (1999) (1)
- Are personality disorders in bipolar patients more frequent in the US than Europe? (2022) (1)
- The range of hypo/manic severities on antidepressants by the daily LCM (2004) (1)
- Acute Ketamine Modulated Functional Brain Coupling and Dissociative and Affective States in Human Subjects: Interim Analyses (2021) (1)
- Stimulants for Adult Bipolar Disorder? Adding a Stimulant Could Improve Residual Symptoms, but It Also Might Cause Serious Side Effects, Toxicities, and Destabilization (2008) (1)
- 573 The atypical antipsychotic sertindole: A case series (1997) (1)
- Cost-utility and cost-effectiveness analyses of an internet-based self-management program for bipolar disorder: Randomised controlled trial (Preprint) (2022) (0)
- Rapid cycling bipolar disorder: A new treatment option (2000) (0)
- Design of clinical trials in bipolar disorders (2012) (0)
- Bipolar disorders in DSM-5: Changes and implications for clinical research (2016) (0)
- P 07 Long-term lithium treatment and thyroid antibodies – a study of 100 patients with affective disorders and 100 normal controls (2004) (0)
- Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder. (2019) (0)
- Quetiapine for the Treatment of Depression Associated with Bipolar Disorder--Selected Posters (2008) (0)
- 96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression (2023) (0)
- Gabapentin ( Neurontin ® ) in the acute treatment of refractory bipolar disorder (0)
- Background Few studies have examined the relative risks of switching into hypomania ormania associatedwith second-generation antidepressantdrugs in bipolardepression. Aims To examine therelative acute effects of bupropion, sertraline and venlafaxine as adjuncts tomood (2006) (0)
- P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression (2022) (0)
- Bipolar and Related Disorders (2019) (0)
- Bipolar Mixed States: An ISBD Task Force Report of Symptom Structure, Course of Illness, and Diagnosis (2012) (0)
- A pilot trial of quetiapine, lithium, or placebo added to divalproex sodium for hypomanic or manic episodes in ambulatory adults with bipolar I disorder (2022) (0)
- More Stressors and Bipolar Illness Adversity in US than Europe (2011) (0)
- A brief commentary on the Bipolar CHOICE study. (2016) (0)
- 44. Acute Effects of MDMA on Negative Affective Brain Circuit Function: A Randomized Controlled Mechanistic Trial (2023) (0)
- Stanley foundation bipolar network: predictors of psychosocial outcome (2016) (0)
- Use of quetiapine in bipolar disorder: a case series with prospective evaluation : a case series with prospective evaluation (2004) (0)
- Clinical Utility of Clozapine in Bipolar Disorder (2011) (0)
- A SYSTEMATIC REVIEW OF PSILOCYBIN IN THE TREATMENT OF DEPRESSION AND ANXIETY (2019) (0)
- C.18.02 Clinical trial design in the long-term treatment of bipolar disorder: patient considerations (2008) (0)
- Four generations of US patients are more ill than those from the Netherlands and Germany (2016) (0)
- Gender Differences in Bipolar Disorder (2006) (0)
- Rapid cycling bipolar disorder: a 5-year prospective follow-up (2004) (0)
- 43. Acute Effects of MDMA on Intrinsic Functional Connectomes Associated With Altered States of Consciousness and Defensiveness (2023) (0)
- CPNP 2019 Annual Meeting Poster Abstracts (2019) (0)
- Switch rates of new-generation antidepressants in adjunctive treatment of bipolar depression (2006) (0)
- Maintenance Treatments in Bipolar Disorder (2015) (0)
- Combination Treatment With Quetiapine in Bipolar Disorder Patients (2009) (0)
- P165. Circadian Sub-Groups in Bipolar I Disorder (2022) (0)
- Increased risk factors and poor long-term outcome in the US compared to Holland and Germany (2010) (0)
- Reply (2002) (0)
- Implications and impressions of the ISBD Task Force DSM5 on mixed depression in bipolar disorder (2015) (0)
- Brief Bipolar Disorder Symptom Scale (2015) (0)
- 108. rCBF changes with clozapine treatment in refractory bipolar disorder (1996) (0)
- P.1.214 Lamotrigine controls bipolar depression without destabilising mood: An analysis of data from 8 placebo-controlled trials (2003) (0)
- University of Groningen Role of childhood adversity in the development of medical comorbidities associated with bipolar disorder (2017) (0)
- Chronbiologically-based sub-groups in bipolar I disorder: A latent profile analysis. (2021) (0)
- P341. Acute Ketamine Modulates Cognitive Control Network Activity During Cognitive Inhibition: Evidence From a Mechanistic Trial (2022) (0)
- PW01-38 - Maintenance Treatment With Quetiapine Added To Either Lithium or Divalproex In Bipolar I Disorder (2010) (0)
- Implementing guidelines and systems of care (1999) (0)
- Welcome Letter. (2019) (0)
- Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants. (2019) (0)
- Lamotrigine: Safety data from controlled monotherapy trials in depression (1999) (0)
- Bipolar illness in the United States compared to the Netherlands and Germany (2011) (0)
- Obesity and Obstetric Complications are Associated with Rapid-cycling in Italian Patients with Bipolar Disorder (2017) (0)
- Contents of the American Journal of Psychiatry (2016) (0)
- 318. Mood changes during corticosteroid exposure: Preliminary data (1998) (0)
- Mixed bipolar states at first hospitalization (1994) (0)
- C.04.01 Towards diagnosis of depressive symptoms during manic episodes: the DSM-5 mixed specifier (2014) (0)
- Question-and-Answer Forum (2006) (0)
- P.3.c.061 Maintenance treatment with quetiapine added to either lithium or divalproex in bipolar I disorder (2009) (0)
- Lurasidone Effective in Major Depressive Disorder With Mixed Features: RESOLVE2 (2015) (0)
- Special Report: Bipolar Disorder II—Frequently Neglected, Misdiagnosed (2023) (0)
- Maintenance Treatment of Bipolar Disorder : An Expert Interview With (0)
- Abstracts from the 3rd Biennial Conference of the International Society for Bipolar Disorders. January 27-28, 2008. Delhi, India. January 30, 2008. Agra, India. (2008) (0)
- 539. Ketamine’s Acute Effects on Negative Brain States are Mediated Through Distinct Altered States in Humans (2023) (0)
- Bipolar Disorder 2017 (Advances in Psychotherapy: Evidence Based Practice) (2017) (0)
- Charles Bowden, MD, 1938-2022. (2022) (0)
- The Spectrum of Rapid Cycling (2004) (0)
- 5 – Neurophysiological and cognitive phenotypes across the schizophrenia–bipolar disorder boundary (2008) (0)
- Awareness of the metabolic syndrome in patients with bipolar disorder: A comparison of US and European psychiatrists (2008) (0)
- P226. Deconstructing Ketamine-Induced Changes in Cortisol and Dissociative and Affective States in a Controlled Mechanistic Study (2022) (0)
- Development of an online interactive self-help program for significant others: www.iCARE4bipolar.com (2015) (0)
- Activation of Cognitive Control Network During Inhibition Processing Dynamically Predicts Symptom Outcomes for Depression: A 24-month Longitudinal Study (2021) (0)
- Understanding treatment response to integrated behavior therapy for comorbid obesity and depression in primary care (2018) (0)
- Strategies for Shifting From Acute to Maintenance Treatment for Bipolar I Disorder. (2020) (0)
- Ethical dilemmas of participant safety monitoring in online clinical research (2015) (0)
- Psychopharmacology of Bipolar II Depression and Bipolar Depression with Mixed Features (2014) (0)
- 472. Resting-State Functional Connectivity Dysfunction of the Ventral Striatum in Anhedonia as a Transdiagnostic Process (2017) (0)
- eHealth approaches to the management of bipolar disorder across the lifespan: Results and implications of three tech‐based RCTs Chair Anna Van Meter (2019) (0)
- Cost-utility and cost-effectiveness analyses of MoodSwings 2.0: An internet-based self-management program for bipolar disorder (Preprint) (2022) (0)
- Early Change in Neural Circuit Function Engaged by Negative Emotion Mediates Later Depression and Problem-Solving Outcomes Following Behavioural Intervention (2020) (0)
- Discussion forum engagement within an internet-based program for bipolar disorder: impacts on social support, stigma, quality of life and mood severity (2017) (0)
- What are the new treatments for bipolar disorder? (1998) (0)
- Discussion board utilization within an online self-help program for bipolar disorder (MoodSwings 2.0) (2015) (0)
- The pros and cons of online recruitment (2015) (0)
- Blinded 12-month maintenance treatment for bipolar i disorder (2000) (0)
- User engagement within the moodswings 2.0 online self-guided intervention for bipolar disorder (2017) (0)
- PMH75 DEVELOPMENT OF A PATIENT-REPORTED INSTRUMENT TO ASSESS THE FUNCTIONAL STATUS OF PATIENTS WITH BIPOLAR DISORDER (2004) (0)
- Cost-Utility and Cost-effectiveness of MoodSwings 2.0, an Internet-Based Self-management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial (2022) (0)
- Adjunctive Lumateperone (ITI-007) in the Treatment of Bipolar Depression: Results From a Randomized Placebo-Controlled Clinical Trial. (2023) (0)
- 533. The effects of clozapine on sleep EEG in bipolar illness (1996) (0)
- Metabolic syndrome among patients with bipolar disorder: Current perspectives of European psychiatrists (2007) (0)
This paper list is powered by the following services:
Other Resources About Trisha Suppes
What Schools Are Affiliated With Trisha Suppes?
Trisha Suppes is affiliated with the following schools:
